AIM Breakfasts

AIM BREAKFAST – 16th November 2016

Set Menu AIM:

Total number of AIM Companies (Incl Susp): 994

Total number of AIM Companies trading: 970*
* As at 15 November 2016

Dish of the Day:

FreeAgent Holdings (FREE.L) has joined AIM raising £10.7m at 84p

Off the Menu:

No Aim Leavers Today

Set Menu ISDX Growth:

Total number of ISDX Growth Market Companies (Incl Susp): *

Total number of ISDX Growth Market Companies trading: *
* As at 15 November 2016

Dish of the Day:

Off the Menu:

What’s Cooking in the IPO Kitchen?

United Global—According to Arabian Business the merged UAE Exchange/Travelex is seeking a LSE float in Q3 2017 with 30% of the shares to be made public

Diversified Gas & Oil—The US based gas and oil producer is seeking a December AIM quoting to raise circa $60m

 

Breakfast Buffet

AB Dynamics (ABDP.L) 467.5p £83m

FYAug16 results from the designer, manufacturer and supplier of advanced testing systems and measurement products to the global automotive industry. Revenue increased 23.9% to £20.5 million. Operating profit increased 16% to £4.4 million. Final dividend of 1.815 pence per ordinary share, 3.025 pence for the year up 10% . Order book covers revenues to Q3 2017. FYAUG17E revenue £24.5m, EPS28p, Dividend 3.3p  16.7xPE 0.7% yield.

 

Ergomed (ERGO.L) 126p £50.23m

The provider of specialised services to the pharmaceutical industry and the development of new drugs noted that its co-development partner Modus Therapeutics Holding AB has announced that following a planned safety review by an independent Data Safety Monitoring Board, adolescents between the ages of 12 and 18 can now be enrolled in its ongoing Phase II clinical study with sevuprin in Sickle Cell Disease.  In addition, the Company has decided to expand the study sample size to 150 patients with top line results now expected in H1 2018 rather than in H1 2017.

 

Toople (TOOP.L) 5.25p £5.25m

Trading update from the main market  listed  provider of bespoke telecom services to UK SMEs. Since the launch of Toople.com in May the Company has been steadily increasing the number of customers it attracts to its platform, and is now provisioning over 200 new orders on average per month. The Directors are targeting a significantly increased average monthly order rate during 2017.  Recently  accredited by >30 of UKs biggest B2B cashback and comparison sites including; uSwitch, Quidco, Topcashback, & Broadband Genie.

 

Georgian Mining Corp (GEO.L) 8.25p £3.95m

The Company has raised £2.6m by way of an oversubscribed placing  at 8p. The net proceeds of the Placing  will be used to facilitate the Company’s strategy to deliver an initial resource of between 3 and 5 million tonnes of open pit copper-gold sulphide mineralisation at the Kvemo Bolnisi Copper-Gold Project in Georgia  together with gold oxide mineralisation that has been reported previously. This will enable the use of 1M tonnes annual excess capacity which is available at its partner’s flotation plant  at the producing Madneuli Mine, just 7km from the project .

 

Horizon Discovery Group (HZD.L) 125p £119m

The specialist in the application of gene editing technologies, announced that it has entered into  partnerships with three leading Chinese diagnostic kit developers. Under the terms of the agreements, Horizon will provide HDx Reference Standards for novel Next Generation Sequencing assay development, clinical trials, and ultimately for inclusion as in-kit controls under Original Equipment Manufacturer  agreements.  FYDec16E revenue of £24.96m and a £10.7m pre-tax loss.

 

Koovs (KOOVS.L) 63p £94.3m

Koovs  announced a strategic investment from the Times of India Group (£3.9m) as part of a further £10.9m of new funding, and up to an additional £2m via Broker Option. This capital raise is part of the final tranche of the Company’s three-year investment programme to raise approximately £35 million, announced in September 2015.  It brings the total raised under this programme to £31 million to date. The issue price of this latest round is 50p. FYMar17 in line. Consensus revenue £18.4m, £17m pre-tax loss.

 

Frontera Resources (FRR.L) 0.1p £7.93m

The independent oil and gas exploration and production company, announced that its fully owned subsidiary Frontera Resources International LLC has been chosen as winner of the bidding for exploration and production of hydrocarbons in the Republic of Moldova. The exploration and development agreements  are subject to both Frontera Resources International LLC and the Government of Moldova negotiating suitable terms for the exploration and development of hydrocarbons outlined in the initial bidding process.

 

European Metals (EMH.L) 33.5p £41.5m

EMH has announced analytical results for the confirmation drillholes CIW-13, CIW-14 and CIW-18 at the Cinovec Lithium-Tin-Tungsten Project  which all confirmed or exceeded the expected lithium content and mineralisation widths.   The best results are from CIW-14: 82m averaging 0.48% Li2O, and 175m averaging 0.40%Li2O.  The first interval includes high-grade intervals 4m @1.07%Li2O and 4m @1.58%Li2O. Cinovec in the Czech Republic is the largest lithium deposit in Europe and the fourth largest non-brine deposit in the world.

 

Lightwave RF (LWRF.L) 21p £4.32m

The proprietary IOT platform and connected devices specialist enabling the remote control and monitoring of light, heat, power and security through just one App, has raised £1 million (before expenses) through a subscription at 13p.  A 7.1% discount to the average price over the last 30 trading days. The Subscription proceeds will be used to further develop the sales and marketing activities of the business as well as accelerate new product development.

 

IXICO (IXI.L) 24.5p £6.49m

The brain health company, announced its participation in a new collaborative pan-European research effort under the Innovative Medicines Initiative’s  umbrella focused on addressing the challenges of successfully delivering therapies to people with Alzheimer’s disease. In this collaboration with leading pharmaceutical companies and academics, IXICO is receiving 100k of funding to undertake data aggregation & analysis using its digital technology platforms. There are no forecasts in the market.

 

Head Chef:

Derren Nathan
0203 764 2344
derren.nathan@hybridan.com

*A corporate client of Hybridan LLP

Disclaimer

This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity and is not a personal recommendation to anyone. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.

Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, does not constitute “independent investment research” for the purposes of the Financial Conduct Authority rules. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, directors, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the UK, this document is directed at and is for distribution only to persons who (i) fall within Article 19(5) (persons who have professional experience in matters relating to investments) or Article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) or (ii) are Professional Clients or Eligible Counterparties (as those terms are defined in the rules of the Financial Conduct Authority) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as “relevant persons”). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by persons who would be classified as Retail Clients (as defined by the rules of the Financial Conduct Authority).

Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of UK or US securities law, or the law of any such other jurisdictions.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, directors, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

Neither the whole nor any part of this document may be duplicated in any form or by any means. Neither should this document, or any part thereof, be redistributed or disclosed to anyone without the prior consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX. If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.